Uma Alampur, MD
Neurology · Ossining, NYNPI 1457348393
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 260 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,435 and has fallen 91.7% since, to $120 in 2025.
Across 260 payments — averaging $21.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Biogen$1K
- AstraZeneca$691
- Lilly USA, LLC$601
- Argenx US, Inc.$460
- Novartis$413
- plus $1K from 14 others
What the payments were for
- Food & beverage$5,518100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 62 | $1,299 |
| Biogen | 45 | $1,053 |
| AstraZeneca | 30 | $691 |
| Lilly USA, LLC | 26 | $601 |
| Argenx US, Inc. | 21 | $460 |
| Novartis | 29 | $413 |
| Pfizer | 18 | $350 |
| Johnson & Johnson | 6 | $199 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $96 |
| Eisai Inc. | 3 | $64 |
| Biohaven Pharmaceuticals, Inc. | 3 | $58 |
| SK Life Science, Inc. | 2 | $54 |
| Amgen(2 entities) | 2 | $45 |
| Catalyst Pharmaceuticals, Inc. | 2 | $31 |
| Grifols USA, LLC | 1 | $23 |
| UCB, Inc. | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Tanabe Pharma America, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,518 in reported general payments places this provider in the 70th percentile of 1,623 neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pyridostigmine Bromide | 79 | $5,706 |
| Memantine Hcl | 122 | $2,689 |
| Azathioprine | 25 | $1,768 |
| Memantine Hcl ErMemantine Hcl | 12 | $1,719 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 45 | $1,286 |
| Gabapentin | 51 | $1,010 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 18 | $921 |
| Lamotrigine | 36 | $913 |
| Levetiracetam | 15 | $645 |
| Prednisone | 90 | $622 |
| Divalproex Sodium | 13 | $576 |
| Clobazam | 11 | $561 |
| Trazodone Hcl | 84 | $556 |
| Baclofen | 15 | $439 |
| Ropinirole Hcl | 11 | $306 |
Paid to pharmacies, not to this prescriber.
Other neurology in Ossining
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
- Jennifer McVigeAmherst$982K
- Warren SpinnerPort Jefferson Station$791K
- Richard LiptonBronx$753K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.